- BIVI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
BioVie (BIVI) CORRESPCorrespondence with SEC
Filed: 1 Feb 21, 12:00am
BioVie Inc.
2120 Colorado Avenue, #230
Santa Monica, California 90404
February 1, 2021
Tim Buchmiller
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F. Street, NW
Washington, D.C. 20549
Re: | Biovie Inc. (the “Company”) Registration Statement on Form S-3 File No. 333-252386 |
Dear Mr. Buchmiller:
The Company hereby requests that the effective date and time of the above referenced Registration Statement be accelerated to 5:00 pm on February 2, 2021 or as soon thereafter as practicable, pursuant to Rule 461 of the Securities Act of 1933, as amended.
Sincerely,
BIOVIE INC.
/s/ Joanne Wendy Kim
By:____________________________
Name: Joanne Wendy Kim
Title: Chief Financial Officer and Corporate Secretary